Vacunas durante el embarazo.

The response to vaccines during pregnancy can be variable, however, we have no evidence of a decrease in their effectiveness. Furthermore, the protective effect of vaccines during pregnancy has been documented for more than a century. Pregnant women are vulnerable to influenza virus infections, presenting higher morbidity and mortality rates. Influenza vaccination with a non-adjuvanted inactivated vaccine, preferably quadrivalent, is recommended for all pregnant women in any trimester of pregnancy. Infection by Bordetella Pertussis, especially in children under 3 months of age, is of great risk. Vaccination during pregnancy aims to protect the newborn during the first months of life, through the passive transfer of antibodies and to prevent the woman from acquiring whooping cough and infecting the newborn. Pregnancy is a risk factor for greater severity of SARS-CoV-2 infection, therefore, pregnant women constitute a priority group for vaccination. The vaccine should be offered to pregnant women just as it is to the rest of the population, since the benefits of its administration most likely outweigh the risks of suffering from the infection. It is especially important to offer it to pregnant women with comorbidities. Every pregnant woman should be advised about the importance and benefits of vaccination for herself and her children. Today influenza vaccines, the TDaP vaccine and the COVID-19 vaccine are indicated. [ABSTRACT FROM AUTHOR]